Sarepta Therapeutics, Inc.
Combination Therapies for Treating Muscular Dystrophy

Abstract:

The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.